κατσικα.png

Lithography that represents the healing properties of dictamnus. (Amsterdam, 1703)
 
 
 

Description - properties-dittany usage

Scientific name: Origanum dictamnus
Foreign languages names : English: Dittany of Crete, dictamna hops, Dictamnus German: Diptamdosten, Kretadiptam, Dictamno, Kreta-Majoran
Italian: Origano de Creta, dittamo diCandia, dittamo Cretico
French: Dictame de Crete
 
Diktamos (or Erontas), is an indigenous plant of Crete and its name derives from the mountain of Crete “Dikti” and the word “thamnos” which means “shrub” in Greek. It is a native plant found on steep cliffs and cliffs in various mountainous areas of Crete. (Mount Dikti, White Mountains, Psiloritis, etc.) It is a small perennial shrub, 20-40cm long and can be easily recognized by the distinctive soft, woolly covering of white-grey hair on its stems, its round green leaves and the violet-purple flowers. It is considered to be one of the most important medicinal plants known in Minoan Crete and Ancient Greece. Hippocrates prescribed plant cures to aid all manner of ailments, and considered dittany of Crete useful for stomach aches and complaints of the digestive system and as a poultice for healing wounds, as well as inducing menstruation. The Greek philosopher Aristotle in his work "The History of Animals" wrote: “Wild goats on Crete are said, when wounded by an arrow, to go in search of dittany, which is supposed to have the property of ejecting arrows in the body.” Its healing properties are mentioned by many ancient authors such as Homer, Aristotle, Virgil, Plutarch, and others. Nowadays, dictamnus is known to have many therapeutic properties such as antioxidant, healing, pain-killing, antimicrobial, rejuvenating, antipyretic, antiseptic, soothing of the digestive system, aphrodisiac, and even anti-cancer properties. It relieves period pains, cough from colds, headaches, etc. 

 https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-origanum-dictamnus-l-herba_en.pdf

https://rua.ua.es/dspace/bitstream/10045/51668/2/2015_Martinez-Frances_etal_JEthnopharm_accepted.pdf